...
首页> 外文期刊>The international journal of biochemistry and cell biology >MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6
【24h】

MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6

机译:通过抑制CDK6,通过抑制细胞增殖,迁移和侵袭作为口腔鳞状细胞癌中的肿瘤抑制剂用作肿瘤抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNA (miRNA), as tumor suppressor or oncogene, is involved in the regulation of tumor development. However, the role of miRNA in human oral squamous cell carcinoma (OSCC) is less well understood. In our previous studies, we have successfully established a Chinese hamster oral squamous cell carcinoma animal model and constructed a miRNA differential expression profile, and screened out the abnormal expressed gene (miR-504). The purpose of this study was to investigate the regulatory mechanism of miR-504 in human OSCC cells and to elucidate its new target genes. CCK-8 assay, colony formation assay, transwell migration and invasion assay were used to test the cell proliferation, cell growth, cell migration and cell invasion abilities of the miR-504 mimics group, respectively. Flow cytometry was used to detect the apoptotic ability. In order to verify the direct target of miR-504, we used the dual luciferase reporting system for detection. The expressions of RNA and proteins were detected by qRT-PCR and western blotting. The results of our study showed that miR-504 expression was down-regulated in OSCC animal tissue samples. In human OSCC cell lines, miR-504 over-expression significantly inhibited cell proliferation, migration and invasion. The dual luciferase reporting system confirmed that CDK6 was a direct target of miR-504 and that miR-504 expression inhibited CDK6 expression. In addition, the over-expression of miR-504 in OSCC cells could significantly inhibit the expression of cell cyclerelated proteins (E2F1, Cyclin Dl), but the expression of p21 was significantly increased. The results of this study suggest that miR-504 may be a new therapeutic target for OSCC.
机译:microRNA(miRNA)作为肿瘤抑制剂或癌基因,参与肿瘤发育的调节。然而,miRNA在人口腔鳞状细胞癌(OSCC)中的作用不太了解。在我们以前的研究中,我们已成功建立了中国仓鼠口腔鳞状细胞癌动物模型,并构建了miRNA差异表达谱,并筛选出异常表达基因(miR-504)。本研究的目的是探讨MIR-504在人体OSCC细胞中的调节机制,并阐明其新的靶基因。 CCK-8测定,菌落形成测定,转发迁移和侵袭测定分别用于分别测试MIR-504模拟组的细胞增殖,细胞生长,细胞迁移和细胞侵袭能力。流式细胞术用于检测凋亡能力。为了验证miR-504的直目标,我们使用双荧光素酶报告系统进行检测。通过QRT-PCR和Western印迹检测RNA和蛋白质的表达。我们的研究结果表明,MIR-504表达在OSCC动物组织样品中受到了下调。在人类OSCC细胞系中,miR-504过表达显着抑制细胞增殖,迁移和侵袭。双荧光素酶报告系统证实CDK6是miR-504的直接靶标,并且miR-504表达抑制了CDK6表达。此外,OSCC细胞中miR-504的过表达可显着抑制细胞环化蛋白(E2F1,细胞周期蛋白D1)的表达,但P21的表达显着增加。该研究的结果表明miR-504可以是OSCC的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号